Lee S. Schwartzberg
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Surgery top 2%
- Cancer Research top 1%
- Hematology top 0.5%
- Co-authors
- Rudolph M. NavariArthur C. HoutsRobert BirchB HazeltonMark S. WalkerBarry FortnerCathy AllenW. H. West
- Topics
- Cancer Treatment and Pharmacology (94 papers)Nausea and vomiting management (77 papers)Lung Cancer Treatments and Mutations (64 papers)
- Cited by
- OncologyHematologyCancer Research
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Lee S. Schwartzberg
402 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 6.0k
- Pulmonary and Respiratory Medicine 2.3k
- Surgery 1.7k
- Cancer Research 1.5k
- Hematology 1.5k
Countries citing papers authored by Lee S. Schwartzberg
This map shows the geographic impact of Lee S. Schwartzberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee S. Schwartzberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee S. Schwartzberg more than expected).
Fields of papers citing papers by Lee S. Schwartzberg
This network shows the impact of papers produced by Lee S. Schwartzberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee S. Schwartzberg. The network helps show where Lee S. Schwartzberg may publish in the future.
Co-authorship network of co-authors of Lee S. Schwartzberg
This figure shows the co-authorship network connecting the top 25 collaborators of Lee S. Schwartzberg. A scholar is included among the top collaborators of Lee S. Schwartzberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee S. Schwartzberg. Lee S. Schwartzberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 7 | |
| 8 | 6 | |
| 9 | 16 | |
| 10 | 12 | |
| 11 | 17 | |
| 12 | 9 | |
| 13 | 42 | |
| 14 | 166 | |
| 15 | PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancerbreakdown → | 478 |
| 16 | Payer and provider collaborations that improve quality outcomes in oncology. | 1 |
| 17 | 250 | |
| 18 | A prospective investigation of chemotherapy-induced neutropenia and quality of life. | 11 |
| 19 | 10 | |
| 20 | 51 |
About Lee S. Schwartzberg
Lee S. Schwartzberg is a scholar working on Oncology, Cancer Research and Family Practice, having authored 422 papers that have together received 10.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (94 papers), Nausea and vomiting management (77 papers) and Lung Cancer Treatments and Mutations (64 papers). The work is most often cited by research in Oncology (6.0k citations), Hematology (1.5k citations) and Cancer Research (1.5k citations). Lee S. Schwartzberg has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Rudolph M. Navari, Arthur C. Houts, Robert Birch, B Hazelton, Mark S. Walker, Barry Fortner, Cathy Allen, W. H. West, Meinolf Karthaus and C H Weaver. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.